Perrot-Applanat M, Cibert C, Géraud G, Renoir J M, Baulieu E E
INSERM U135 Hormones et Reproduction, Faculté de Médecine de Bicêtre, Kremlin-Bicêtre, France.
J Cell Sci. 1995 May;108 ( Pt 5):2037-51. doi: 10.1242/jcs.108.5.2037.
FKBP59-HBI, a 59 kDa FK506 binding protein which binds the 90 kDa heat shock protein hsp90 and thus is a heat shock protein binding immunophilin (HBI), was originally discovered in association with unliganded steroid receptors in their heat shock protein containing heterooligomer form. It belongs to a growing family including other FKBPs which bind the immunosuppressants FK506 and rapamycin, and cyclophilins which bind cyclosporin A, all having rotamase (peptidyl-prolyl cis-trans isomerase) activity which may be involved in protein folding. Targets for drug-immunophilin complexes have been mostly studied in vivo in T lymphocytes; however, immunophilins are present in all cell types, where their role and distribution are still unknown. Here we report the localization of FKBP59-HBI in various non lymphoid cells (mouse fibroblasts (L-929), monkey kidney cells (Cos-7), Madin-Darby canine kidney epithelial cells (MDCK), and mouse neuronal cells (GT1)). Two polyclonal antipeptide antibodies directed against the C-terminal end (amino acids 441-458) (Ab 173) or the sequence 182-201 (Ab 790) of the FKBP59-HBI were used in light and confocal laser immunofluorescence. FKBP59-HBI was found in the cytoplasm and nucleus of interphase cells. Specific immunofluorescence was much stronger in the cytoplasm than in the nucleus when using Ab 173, and stronger in the nucleus than in the cytoplasm with Ab 790. Detailed observations of L-cells, which have a particularly flat morphology, showed a punctate as well as a fibrous cytoskeletal staining in the cytoplasm using antibody 173, a result which suggests interactions of FKBP59-HBI with an organized network. Colocalization experiments (using antibodies against tubulin, vimentin or actin) and use of cytoskeletal-disrupting drugs revealed partial association of FKBP59-HBI with the microtubules. Western blot experiments confirmed that the protein was present in the subcellular fractions containing either 'soluble' proteins released from cells exposed to NP40 detergent, or proteins released from the cytoskeleton exposed to calcium ions (i.e. in microtubule depolymerizing conditions). Exposure of cells to 1 microM FK506 and rapamycin for 1 hour did not modify significantly the staining, although rapamycin treatment rendered the network stained by 173 clearly visible. Interestingly, during mitosis FKBP59-HBI segregated from the region of the chromosomes; it mainly localized with the mitotic apparatus (centrosome, spindle and interzone separating the chromosomes), the cleavage furrow and the midbodies during cytokinesis. It appeared again as a fibrous network in the cytoplasm of the two daughters cells.(ABSTRACT TRUNCATED AT 400 WORDS)
FKBP59-HBI是一种59 kDa的FK506结合蛋白,它能与90 kDa的热休克蛋白hsp90结合,因此是一种热休克蛋白结合亲免素(HBI),最初是在未结合配体的类固醇受体以含有热休克蛋白的异源寡聚体形式存在时被发现的。它属于一个不断扩大的家族,包括其他能结合免疫抑制剂FK506和雷帕霉素的FKBP,以及能结合环孢菌素A的亲环蛋白,它们都具有可能参与蛋白质折叠的肽基脯氨酰顺反异构酶(旋转异构酶)活性。药物-亲免素复合物的靶点大多在体内T淋巴细胞中进行了研究;然而,亲免素存在于所有细胞类型中,其作用和分布仍不清楚。在此,我们报告了FKBP59-HBI在各种非淋巴细胞(小鼠成纤维细胞(L-929)、猴肾细胞(Cos-7)、马-达二氏犬肾上皮细胞(MDCK)和小鼠神经细胞(GT1))中的定位。针对FKBP59-HBI的C末端(氨基酸441-458)(抗体173)或序列182-201(抗体790)的两种多克隆抗肽抗体用于光镜和共聚焦激光免疫荧光。在间期细胞的细胞质和细胞核中发现了FKBP59-HBI。使用抗体173时,特异性免疫荧光在细胞质中比在细胞核中强得多,而使用抗体790时,在细胞核中比在细胞质中强。对形态特别扁平的L细胞的详细观察表明,使用抗体173时,细胞质中有斑点状以及纤维状细胞骨架染色,这一结果表明FKBP59-HBI与一个有组织的网络相互作用。共定位实验(使用抗微管蛋白、波形蛋白或肌动蛋白的抗体)以及使用破坏细胞骨架的药物揭示了FKBP59-HBI与微管的部分关联。蛋白质印迹实验证实,该蛋白存在于亚细胞组分中,这些组分要么含有从暴露于NP40去污剂的细胞中释放的“可溶性”蛋白,要么含有从暴露于钙离子的细胞骨架中释放的蛋白(即在微管解聚条件下)。细胞暴露于1 microM FK506和雷帕霉素1小时后,染色没有明显改变,尽管雷帕霉素处理使抗体173染色的网络清晰可见。有趣的是,在有丝分裂期间,FKBP59-HBI从染色体区域分离;在胞质分裂期间,它主要定位于有丝分裂装置(中心体、纺锤体和分离染色体的中间区)、分裂沟和中间体。它在两个子细胞的细胞质中再次呈现为纤维状网络。(摘要截断于400字)